
Organization · Family Office
Aurum Ventures MKI Ltd.
Aurum Ventures MKI Ltd. is a technology investment arm based in Ramat Gan, Israel, focusing on healthcare and life sciences. It provides growth capital to entrepreneurs in various technology sectors, particularly those with cutting-edge innovations.
Overview
What Aurum Ventures MKI Ltd. does
What Aurum Ventures MKI Ltd. is
Aurum Ventures MKI Ltd. is a technology investment arm based in Ramat Gan, Israel, focusing on healthcare and life sciences. It provides growth capital to entrepreneurs in various technology sectors, particularly those with cutting-edge innovations.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Family Office
- Structured capabilities
- Funder
- Last reviewed
- May 1, 2026
Official channels
Find Aurum Ventures MKI Ltd. elsewhere
Open the official website or a supported primary organization account.
Capability profile
Aurum Ventures MKI Ltd. as a funder
Investment thesis
Aurum Ventures MKI Ltd. focuses on long-term value creation in healthcare and life sciences, investing in unique, cutting-edge technologies that contribute to human well-being.
Focus narrative
Aurum Ventures invests primarily in technology-related sectors, with a strong emphasis on healthcare and life sciences. The organization has a history of facilitating the entry of global corporations into the Israeli market and is committed to supporting innovative companies that can make a significant impact in their fields.
Value beyond capital
Aurum Ventures provides value-added growth capital to its portfolio companies, emphasizing a hands-on, long-term approach. The team works closely with entrepreneurs to enhance their strategic and execution capabilities, particularly in navigating the complex clinical, regulatory, and commercialization timelines typical in healthcare and life sciences.
Terms and economics
- Typical check
- $100,000–$5,000,000
Focus and fit
- Stages
- Pre-seed · Seed · Seed+ · Series A · Series B · Growth Equity
- Sectors
- Healthcare · Biotech · Diagnostics · Digital Health · Regenerative Medicine
- Regions
- Global · United States
Availability
- Currently deploying
- Not published
Portfolio and track record
Portfolio context
Notable portfolio companies include: Amdocs (NYSE - DOX): A leading provider of customer care and billing software for the telecom industry. Beyeonics: A surgical visualization company utilizing augmented/virtual reality technology. PolyPid: A clinical-stage specialty pharmaceutical company focused on localized drug delivery. Beta-O2: Developing a bio-artificial pancreas for Type 1 diabetes. Zebra Medical Vision: A radiology AI company enhancing imaging workload management. Nucleix: Specializing in non-invasive molecular cancer diagnostics.
Connected ecosystem
Continue from Aurum Ventures MKI Ltd.
These links use structured organization type, sector, and regional relationships. They do not imply endorsement or commercial similarity.
Same organization type
Structured sector focus
Common questions
What to know about Aurum Ventures MKI Ltd.
Upseed classifies Aurum Ventures MKI Ltd. under the Family Office organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 1, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.